Spastic
16
2
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
Exoskeleton Robotic Assisted Gait Training in Spastic Stroke Post Botulinum Toxin A Injection
Task Practice and Spinal Cord Stimulation
EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2)
EXOPULSE Mollii Suit, Motor Function & Stroke (EXOSTROKE 2)
EXOPULSE Mollii Suit, Spasticity, Muscular Oxygenation & Multiple Sclerosis (ENNOX 2)
Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection
Whole Body Vibration in Children With Cerebral Palsy
Motor Learning Approaches From Working on a Vertical Surface in Hemiplegic Children's Upper Limb Motor Skills
Comparison Between Unihemispheric and Bihemispheric TCDS in Subacute Ischemic Stroke Patients
"Validated Language Transfer of the Spinal Cord Injury-Spasticity Evaluation Tool to German Language"
Influence of Radial Extracorpeal Shock Wave in Hemiplegic Shoulder Patients
Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy
Neurodevelopmental Therapy for Spastic Cerebral Palsy
Functional Electrical Stimulation During Walking in Cerebral Palsy
Evaluation of Specialized Water Dance Intervention
Aerobic Exercise and Transcranial Low Laser Therapy in Patients With Central Nervous System Injury